These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 24468275)

  • 1. Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely J; Dore GJ
    Antiviral Res; 2014 Apr; 104():62-72. PubMed ID: 24468275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.
    Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ;
    Int J Drug Policy; 2017 Sep; 47():51-60. PubMed ID: 28683982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of HCV and HIV infections among people who inject drugs.
    Grebely J; Tyndall MW
    Curr Opin HIV AIDS; 2011 Nov; 6(6):501-7. PubMed ID: 22001894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A path to eradication of hepatitis C in low- and middle-income countries.
    Graham CS; Swan T
    Antiviral Res; 2015 Jul; 119():89-96. PubMed ID: 25615583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.
    Grebely J; Matthews GV; Lloyd AR; Dore GJ
    Clin Infect Dis; 2013 Oct; 57(7):1014-20. PubMed ID: 23728143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the detection and management of acute hepatitis C virus infection.
    Martinello M; Matthews GV
    Int J Drug Policy; 2015 Oct; 26(10):899-910. PubMed ID: 26254495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy.
    Bird K; Socías ME; Ti L
    Int J Drug Policy; 2018 Sep; 59():1-2. PubMed ID: 29960218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico.
    Marquez LK; Fleiz C; Burgos JL; Cepeda JA; McIntosh C; Garfein RS; Kiene SM; Brodine S; Strathdee SA; Martin NK
    Addiction; 2021 Oct; 116(10):2734-2745. PubMed ID: 33620750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.
    van Santen DK; de Vos AS; Matser A; Willemse SB; Lindenburg K; Kretzschmar ME; Prins M; de Wit GA
    PLoS One; 2016; 11(10):e0163488. PubMed ID: 27711200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide.
    Tai CM; Yu ML
    Kaohsiung J Med Sci; 2024 Feb; 40(2):112-118. PubMed ID: 38010851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
    Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
    Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.
    Hickman M; De Angelis D; Vickerman P; Hutchinson S; Martin NK
    Curr Opin Infect Dis; 2015 Dec; 28(6):576-82. PubMed ID: 26524330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
    Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting antiviral agents for HCV infection affecting people who inject drugs.
    Grebely J; Hajarizadeh B; Dore GJ
    Nat Rev Gastroenterol Hepatol; 2017 Nov; 14(11):641-651. PubMed ID: 28831184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
    Arain A; Robaeys G
    World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
    Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Dhersin JS; Yazdanpanah Y
    J Viral Hepat; 2015 Mar; 22(3):213-29. PubMed ID: 25270261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.